On July 2021, Regulators in Japan announced they will start conducting inspections by surprise at facilities where drugs, pharmaceuticals and medical devices products are manufactured
Anvisa is accepted as a member of the international API Inspection Programs.
The PMDA clarifies its requirements for conducting remote compliance inspections related to drugs and regenerative medical products.
Therapeutic Goods Administration (TGA) publishes the Good Manufacturing Practices (GMP) approach for oversees manufacturers to assist manufacturers who may undergo remote inspection.
Brazil implements successful Medical Device Single Audit Program (MDSAP) and shows exciting results for the future of international inspection.